Repros Therapeutics, Inc. (RPRX)

[rstor1]

My immediate reaction is that they are trying to do things on the cheap and in the hope to make the cash last a few more days.

Does this move make sense? I don't recall seeing this kind of announcement anywhere else. It may be a testament to JP's transparency or simply done to create buzz to raise the sp ahead of the offering.

If I recall correctly, weren't we counting on some of the enrollment in this trial to go towards the FDA's patient exposure safety requirement?

Regards,
Bob